One of the first tests that allows patients to self-collect samples to screen for human papillomavirus (HPV) will soon be available in doctors' offices.
In May, the U.S. Food and Drug Administration (FDA) approved a self-swab test from global medical technology company Becton, Dickinson and Company (BD) for "clinical" use, meaning in a private room inside a doctor's office, in a mobile clinic, or in another health care setting.
BD told ABC News that it started shipping its self-swab kits, called the BD Onclarity HPV Assay, to doctors' offices on Thursday and that kits will begin arriving at health care facilities later this month.
Please select this link to read the complete article from ABC News.